PublizoomAward notice Supplies
suministro BRIVARACETAM (BRIVIACT) Y ROZANOLIXIZUMAB (RYSTIGGO) PARENTERAL de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- HOSPITAL CLINICO SAN CARLOS
Madrid - Place of performance
- Madrid
- Estimated value
- €735,640 excl. VAT
- Amount awarded
- €735,640 excl. VAT
- Planned end of contract
- 28 February 2028
likely re-tender around August 2027 - Bids received
- 1
- Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 4 September 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
suministro BRIVARACETAM (BRIVIACT) Y ROZANOLIXIZUMAB (RYSTIGGO) PARENTERAL de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos
Awarded to
3 lots
- BRIVIACT 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION 5 ML
- RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 2 ml
- RYSTIGGO 140 MG/ML SOLUCION INYECTABLE, 1 vial de 3 ml
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €350,000
- Median
- €846,164
- A quarter above
- €2,267,877
Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 611222-2026.